BioXcel Therapeutics Operating Margin Growth & History (BTAI)

BioXcel Therapeutics's operating margin was −7,859.97% for fiscal 2025.

View full BioXcel Therapeutics company overview

BioXcel Therapeutics annual operating margin history

BioXcel Therapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−7,859.97%−4892.40 pp
20242024-12-31−2,967.56%+9480.41 pp
20232023-12-31−12,447.97%+30124.03 pp
20222022-12-31−42,572.00%

BioXcel Therapeutics operating margin trends

Across the available reported history, BioXcel Therapeutics's operating margin decreased from −2,967.56% to −7,859.97%, a change of −4892.40 percentage points. The latest reported quarter, Q2 2026, shows −5,600.55%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioXcel Therapeutics filings at SEC.gov ↗